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Sleep-induced amaurosis fugax
Raj P. Shah, BS, and James O. Menzoian, MD, Farmington, Conn
Amaurosis fugax is a manifestation of retinal ischemia, commonly described in the setting of carotid atherosclerotic
disease. Thromboembolic, and less frequently, hemodynamic mechanisms have been described as responsible for
producing negative symptoms of transient monocular vision loss during periods of wakefulness. We report an unusual
presentation in which the patient became symptomatic during sleep. Initially, photopsias-positive symptoms were
experienced, which caused the patient to awaken; this was immediately followed by transient monocular vision loss.
Carotid endarterectomy was curative. ( J Vasc Surg 2011;54:1492-4.)
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gAmaurosis fugax is defined as transient monocular vi-
sion loss, attributed to ischemia or vascular insufficiency. A
typical presentation involves diminished or absent vision in
one eye, which progresses over a few seconds and lasts for
seconds to a few minutes. Its etiology can be classified into
five different categories: embolic, hemodynamic, neuro-
logic, ocular, and uncommonly, idiopathic.1 We report a
unique case of sleep-induced amaurosis fugax, which we
believe has not been presented in any previous publications.
CASE REPORT
An 82-year-old woman presented after three episodes of visu-
alizing bright lights and subsequently losing vision in her right eye.
These events occurred at night, while the patient was asleep. She
was awakened by the bright lights and once awake, realized that
she could not see out of her right eye (this for 2 to 3 minutes). The
first and second episodes occurred on consecutive nights, and the
third was 3 days later. Each episode occurred approximately 4
hours after the onset of sleep. She had no other neurologic
symptoms at the time.
Her medical history was significant for hypertension, hyper-
cholesterolemia, gout, and glaucoma. Medications included feno-
fibrate, hydrochlorothiazide, allopurinol, lisinopril, and aspirin (82
mg/d). She had no history of falls or trauma. The patient had
smoked two to three packs/day for 30 years; however, she quit 12
years ago.
A carotid duplex ultrasound study showed significant calcific
and hypoechoic plaque in both common and internal carotid
arteries (ICA). The peak systolic velocity in the right ICA was 619
cm/s, with an end-diastolic velocity of 190 cm/s; in addition, the
ICA/CCA ratio was 6:1, corresponding to 80% to 99% stenosis. In
the left ICA, the peak systolic velocity was 279 cm/s. Ophthalmo-
logic evaluation was unremarkable. Two weeks after the third
episode, the patient underwent a right carotid endarterectomy
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1492ithout complications. The patient is currently 6 months postpro-
edure and symptom free.
ISCUSSION
Typically, carotid artery occlusive disease is considered
hen evaluating a patient for amaurosis fugax. When pa-
ients have attacks of transient monocular vision loss, with
n onset in seconds and duration of symptoms between 1
nd 10 minutes, they are frequently noted to have a high-
rade stenosis of the ipsilateral ICA.2,3 In recent literature,
maurosis fugax has been associated with common carotid
rtery stenosis to a greater degree than with ICA stenosis.4
ith respect to carotid disease, there are two proposed
tiologies. Most commonly, thromboembolic mechanisms
re responsible, with emboli originating from a carotid
therosclerotic plaque and entering the ipsilateral ophthal-
ic circulation.
The results of a recent study by Verhoeven et al5
rovide insight into the nature of atherosclerotic plaque in
atients with amaurosis fugax. Plaque characteristics were
orrelated with clinical presentation of carotid artery dis-
ase; it was found that plaques of patients with transient
schemic attack and stroke showed significantly higher activity
evels of matrix metalloproteinase-8, -9, and interleukin-8
ompared with asymptomatic and amaurosis fugax patients.
he report suggested that patients with amaurosis fugax had
ecreased prevalence of atheromatous plaques and increased
revalence of collagen-rich plaques.
In our patient, microemboli were of greater concern,
ecause the small platelet-fibrin embolus would more read-
ly manifest in the retina. These were contrasted with the
ore thrombogenic atheromatous plaques, which would
ause larger emboli than fibrous plaques (if ruptured),
eading to greater chances of cerebral ischemic events.
Less frequently, hemodynamic mechanisms have been
iscussed in amaurosis fugax. Exposure to bright light6 or
asospasm7 (in the setting of carotid atherosclerotic dis-
ase), and activities such as exercise8 and sexual inter-
ourse,9 can result in retinal vascular insufficiency. Retinal
igraines have been known to cause transient monocular
isual disturbances–scintillations, scotomas or blindness,
econdary to hypoperfusion.10 Vasospasm of retinal arteri-
les and veins during migraine headaches has been angio-
raphically documented.11 Vasospasm is recognized as a
ause of amaurosis fugax in physically active patients, due to
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exercise, such as including catecholamines and neuropep-
tide Y.8 In these cases, the onset of symptoms is generally
less rapid, develops over minutes (rather than seconds), and
lasts longer than embolic episodes. Symptoms of cerebral
ischemia may also be present.12
Visual symptoms produced by retinal ischemia usually
involve transient monocular vision loss, but photopsias and
scintillations have also been described in this setting.13,14
However, the latter are more common with the diagnosis
of migraines or seizures involving the visual cortex.
Amaurosis fugax caused by a systemic reduction in
blood pressure and subsequently, retinal ischemia, is
relatively uncommon. Nakamura et al15 describe tran-
sient vision loss in a standing position, caused by ortho-
static hypotension. This occurred in a 74-year-old man
with 95% left ICA stenosis, taking tamsulosin hydrochlo-
ride for prostate hypertrophy. Symptoms did not occur
when sitting or supine and were reduced in frequency
after stopping tamsulosin hydrochloride and starting
antithrombotic therapy.
The temporal pattern of our patient’s symptoms com-
pels us to examine how hemodynamic changes in the body
during sleep could cause amaurosis fugax in the setting of
severe carotid stenosis. Baroreceptors are stretch-sensitive
mechanoreceptors that relay action potentials to the nu-
cleus of tractus solitarius. The end result is inhibition of the
sympathetic nervous system and activation of the parasym-
pathetic nervous system. The baroreflex is normally inhib-
ited during the day by input from higher centers; with
sleep, the reflex appears to be released from central inhibi-
tion, and becomes more sensitive. This plays a part in
reducing blood pressure during sleep.16 Thus, we consider
this as a possibility in causing clinically significant hypoper-
fusion to the retina in the setting of severe carotid athero-
occlusive disease during sleep.
In the setting of this patient’s comorbidities, there was
a consideration of the effects of long-standing hypertension
and hypotensive drugs on changes in blood pressure behav-
ior during sleep. A study by Littler et al,17 which included
normotensive, untreated hypertensive, and treated hyper-
tensive patients, showed that there was an almost equal fall
(of 20%) in systolic and diastolic pressures during sleep
compared with their waking blood pressures. Patients with
suboptimally treated hypertension experience greater abso-
lute changes and are subject to greater variability. As a
result, in a hypertensive patient’s sleep cycle, greater-than-
normal changes in blood pressure can result in significantly
reduced end-organ perfusion (retinal ischemia) in the set-
ting of severe carotid stenosis.
It is also necessary to consider the changes that occur
during various stages of sleep. Somers et al18 monitored
sympathetic activity in normal subjects during periods of
wakefulness, rapid eye movement (REM) sleep, and
non-REM sleep. Sympathetic nerve activity, blood pres-
sure, and heart rate are lower in normal individuals while
they are in deep non-REM sleep compared with when
they are awake. Arousal stimuli during non-REM sleep
1licit K complexes, which are accompanied by bursts of
ympathetic activity and transient increases in blood
ressure. During REM sleep, sympathetic nerve activity
ises above levels during wakeful periods, and values of
lood pressure and heart rate return to those at wakeful-
ess. Their study suggested that an increase in sympa-
hetic activity during REM sleep was more significant
han a change in heart rate or blood pressure; therefore,
he latter two measurements underestimated the extent
f autonomic cardiovascular changes.
Finally, they concluded that these sympathetic and
emodynamic changes could act as triggers for throm-
otic events by initiating platelet aggregation or plaque
upture. In this patient, it is possible that rapid changes
n sympathetic activity at different times during sleep
ould have resulted in the rupture of unstable plaque,
nd subsequently, thromboembolism into the ophthal-
ic circulation.
ONCLUSIONS
In addition to prior documented cases of amaurosis
ugax, presumably caused by hemodynamic retinal hypo-
erfusion, this case adds the possibility of sleep as an activity
hat could lead to retinal ischemia in the context of severe
arotid disease. It is unique because this manifestation of
isease symptoms occurred in a state of sleep. In addition, it
resents initially as photopsias, followed by the traditional
ymptom of vision loss, more commonly seen in amaurosis
ugax.
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